Wed, July 26, 2023
Tue, July 25, 2023
Mon, July 24, 2023

Luca Issi Maintained (ALNY) at Buy with Decreased Target to $270 on, Jul 25th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-270-on-jul-25th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Luca Issi of RBC Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Decreased Target from $275 to $270 on, Jul 25th, 2023.

Luca has made no other calls on ALNY in the last 4 months.



There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 3 agree with Luca's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $200 on, Thursday, July 13th, 2023
  • David Hoang of "SMBC Nikko" Initiated at Hold and Held Target at $220 on, Wednesday, April 26th, 2023
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $210 on, Tuesday, April 4th, 2023


These are the ratings of the 2 analyists that currently disagree with Luca


  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $240 on, Friday, May 5th, 2023
  • Kostas Biliouris of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $250 on, Friday, May 5th, 2023